Targeting Psychiatrists: How the Drug Industry Shapes the Nation’s Response to Mental Illness

In two recent articles in the New York Review of Books, Marcia Angell, former editor of the New England Journal of Medicine, reviews several new books on psychiatry, mental illness and the pharmaceutical industry. In the first, she asks why there is an epidemic of mental illness and describes three books that show how the “profession has allied itself with, and is manipulated by, the pharmaceutical industry.” In the second, she describes another four volumes that examine the history of the pharmaceutical industry’s support for psychiatrists and its role in promoting unneeded or risky prescriptions for their products.